Intrinsic Value of S&P & Nasdaq Contact Us

SELLAS Life Sciences Group, Inc. SLS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.80
-42.4%

SELLAS Life Sciences Group, Inc. (SLS) has 12 identified peers for comparison in the Healthcare sector. Peers include ANVS, ARAV, AXSM, CGTX, DAWN, EFTR and others.

SLS has a market capitalization of $692.27M, compared to an average peer market cap of $1.33B.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message